Biotech Basics: How to Spot When Financing Is Coming

Educational content for biotech investing

Gamida Cell ($GMDA) stock is down nearly 20% only a week after the company announced a $23M financing. Similarly, Esperion Therapeutics ($ESPR) was down 6% on news of its own financing last month. Due to their cash-burning nature, biotechs announce offerings regularly. These are usually accompanied by a predictable decline in stock price. Biotech invest…